文献速递肝胆胰外科胃肠外科

肝移植作为胆囊切除术后胆管损伤的根治性治疗:高容量修复中心的经验

Liver Transplantation as Definitive Treatment of Post-cholecystectomy Bile Duct Injury: Experience in a High-volume Repair Center.
PubMed 文献 · Ann Surg · 2021-10-08

该回顾性队列研究基于前瞻性肝移植数据库,分析2008至2019年间因胆囊切除术后胆管损伤(BDI)导致继发性胆汁性肝硬化(SBC)而接受肝移植(LT)的12例患者。BDI相关LT占所有LT的3.4%,术后90天死亡率为16.7%,1、3、5年生存率均为83%。结论认为尽管术后死亡率仍高,LT是唯一治愈可能,长期结果可接受,早期转诊至三级中心至关重要。

要点

  • BDI相关SBC接受LT占所有LT的3.4%,从BDI到SBC诊断中位时间9.3年。
  • 术后并发症发生11例(91.6%),主要为感染(9/12,75%)和肾脏并发症(4/12,33.3%)。
  • 90天死亡率为16.7%,1、3、5年生存率均为83%。

核心结论

  • 尽管BDI在全球范围内是罕见的LT适应证,但在本中心占所有LT的3.4%。
  • 尽管术后死亡率仍高,LT是唯一治愈可能,长期结果可接受。
  • 早期转诊至三级中心对于避免BDI的长期并发症(如SBC)至关重要。

研究设计与样本

  • 回顾性队列研究,来自前瞻性LT数据库。
  • 2008年至2019年间,识别因胆囊切除术后BDI导致SBC需要LT的患者。
  • 分析围手术期和长期结果。

主要发现

  • 在354例LT中,12例患者因胆囊切除术后BDI接受LT,占所有LT的3.4%。
  • 从BDI到SBC诊断的中位时间为9.3年(2.4-14)。
  • 从SBC到列入等待名单的平均时间为2.4年(±2.2)。
  • 术后并发症发生在11例患者(91.6%);主要为感染(9/12患者,75%),其次是肾脏并发症(4/12患者,33.3%)。
  • 仅2例患者发生主要并发症,均为死亡患者,导致90天死亡率为16.7%;平均随访40.3个月(±42.2)后,1、3、5年生存率均为83%。

临床怎么用

  • 对于胆囊切除术后BDI患者,应早期转诊至三级中心以避免长期并发症如SBC。
  • LT是BDI相关SBC患者的唯一治愈可能,尽管术后死亡率仍高,长期结果可接受。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the perioperative and long-term outcomes of patients undergoing LT due to BDI in a tertiary care center. BACKGROUND: BDI is associated with significant morbidity and long-term impact on quality of life. LT represents the only possibility of a cure in patients with BDI who develop SBC. METHODS: Retrospective cohort study from a prospective LT database. Between 2008 and 2019, patients with SBC due to BDI after cholecystectomy and requiring LT were identified. Perioperative and long-term outcomes were analyzed. RESULTS: Among 354 LT, 12 patients underwent LT to treat post-cholecystectomy BDI and accounted for 3.4% of all LT. The median time from BDI to SBC diagnosis was 9.3 years (2.4-14). The mean time from SBC to inclusion on the waitlist was 2.4years (± 2.2). Postoperative complications occurred in 11 patients (91.6%); mainly infectious (9/12 patients, 75%), followed by renal complications (4/12 patients, 33.3%). Only 2 patients developed major complications, which were the patients who died, resulting in a 90-day mortality of 16.7%. After a mean follow-up of 40.3 months (± 42.2) survival at 1, 3, and 5 years was 83%. CONCLUSIONS: Although BDI is an unusual indication for LT worldwide, it accounted for 3.4% of all LT in our center. Although postoperative mortality remains high, LT is the only possibility of a cure, with acceptable long-term outcomes. Early referral to a tertiary care center is essential to avoid long-term complications of BDI, such as SBC.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Vilatobá M, Chávez-Villa M, Figueroa-Méndez R, et al. Liver Transplantation as Definitive Treatment of Post-cholecystectomy Bile Duct Injury: Experience in a High-volume Repair Center. Ann Surg. 2021. PMID: 35084146. doi:10.1097/SLA.0000000000005245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。